The association between adipocytokines and glycemic control in women with gestational diabetes mellitus

References

• Evensen AE. Update on gestational diabetes mellitus. Prim Care. 2012;39(1):83–94.
   PubMed Web of Science ®Google Scholar
• Langer O, Yogev Y, Most O, et al. Gestational diabetes: the consequences of not treating. Am J Obstet Gynecol. 2005;192(4):989–997.
   PubMed Web of Science ®Google Scholar
• Landon MB, Spong CY, Thom E, et al. A multicenter, randomized trial of treatment for mild gestational diabetes. N Engl J Med. 2009;361(14):1339–1348.
   PubMed Web of Science ®Google Scholar
• Crowther CA, Hiller JE, Moss JR, et al. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med. 2005;352(24):2477–2486.
   PubMed Web of Science ®Google Scholar
• Hiersch L, Yogev Y. Management of diabetes and pregnancy – when to start and what pharmacological agent to choose? Best Pract Res Clin Obstet Gynaecol. 2015;29(2):225–236.
   PubMed Web of Science ®Google Scholar
• Committee on Practice Bulletins. Practice Bulletin No. 137: gestational diabetes mellitus. Obstet Gynecol. 2013;122(2 Pt 1):406–416.
   PubMedGoogle Scholar
• Vrachnis N, Belitsos P, Sifakis S, et al. Role of adipokines and other inflammatory mediators in gestational diabetes mellitus and previous gestational diabetes mellitus. Int J Endocrinol. 2012;2012:549748.
   PubMed Web of Science ®Google Scholar
• Miehle K, Stepan H, Fasshauer M. Leptin, adiponectin and other adipokines in gestational diabetes mellitus and pre-eclampsia. Clin Endocrinol (Oxf). 2012;76(1):2–11.
   PubMed Web of Science ®Google Scholar
• Lacroix M, Battista MC, Doyon M, et al. Lower adiponectin levels at first trimester of pregnancy are associated with increased insulin resistance and higher risk of developing gestational diabetes mellitus. Diabetes Care. 2013;36(6):1577–1583.
   PubMed Web of Science ®Google Scholar
• Hedderson MM, Darbinian J, Havel PJ, et al. Low prepregnancy adiponectin concentrations are associated with a marked increase in risk for development of gestational diabetes mellitus. Diabetes Care. 2013;36(12):3930–3937.
   PubMed Web of Science ®Google Scholar
• Briana DD, Malamitsi-Puchner A. Reviews: adipocytokines in normal and complicated pregnancies. Reprod Sci. 2009;16(10):921–937.
   PubMed Web of Science ®Google Scholar
• Rezvan N, Hosseinzadeh-Attar MJ, Masoudkabir F, et al. Serum visfatin concentrations in gestational diabetes mellitus and normal pregnancy. Arch Gynecol Obstet. 2012;285(5):1257–1262.
   PubMed Web of Science ®Google Scholar
• Ferreira AFa, Rezende JC, Vaikousi E, et al. Maternal serum visfatin at 11–13 weeks of gestation in gestational diabetes mellitus. Clin Chem. 2011;57(4):609–613.
   PubMed Web of Science ®Google Scholar
• Misra VK, Straughen JK, Trudeau S. Maternal serum leptin during pregnancy and infant birth weight: the influence of maternal overweight and obesity. Obesity (Silver Spring). 2013;21(5):1064–1069.
   PubMed Web of Science ®Google Scholar
• Nanda S, Poon LCY, Muhaisen M, et al. Maternal serum resistin at 11 to 13 weeks’ gestation in normal and pathological pregnancies. Metabolism. 2012;61(5):699–705.
   PubMed Web of Science ®Google Scholar
• Nanda S, Savvidou M, Syngelaki A, et al. Prediction of gestational diabetes mellitus by maternal factors and biomarkers at 11 to 13 weeks. Prenat Diagn. 2011;31(2):135–141.
   PubMed Web of Science ®Google Scholar
• Savvidou M, Nelson SM, Makgoba M, et al. First-trimester prediction of gestational diabetes mellitus: examining the potential of combining maternal characteristics and laboratory measures. Diabetes. 2010;59(12):3017–3022.
   PubMed Web of Science ®Google Scholar
• Vitoratos N, Deliveliotou A, Dimitrakaki A, et al. Maternal serum resistin concentrations in gestational diabetes mellitus and normal pregnancies. J Obstet Gynaecol Res. 2011;37(2):112–118.
   PubMed Web of Science ®Google Scholar
• Winhofer Y, Handisurya A, Tura A, et al. Osteocalcin is related to enhanced insulin secretion in gestational diabetes mellitus. Diabetes Care. 2010;33(1):139–143.
   PubMed Web of Science ®Google Scholar
• Verhaeghe J, Van Herck E, Bouillon R. Umbilical cord osteocalcin in normal pregnancies and pregnancies complicated by fetal growth retardation or diabetes mellitus. Biol Neonate. 1995;68(6):377–383.
   PubMedGoogle Scholar
• Carpenter MW, Coustan DR. Criteria for screening tests for gestational diabetes. Am J Obstet Gynecol. 1982;144(7):768–773.
   PubMed Web of Science ®Google Scholar
• Meshel S, Schejter E, Harel T, et al. Can we predict the need for pharmacological treatment according to demographic and clinical characteristics in gestational diabetes? J Matern Fetal Neonatal Med. 2016;29(13):2062–2066.
   PubMed Web of Science ®Google Scholar
• Sapienza AD, Francisco RPV, Trindade TC, et al. Factors predicting the need for insulin therapy in patients with gestational diabetes mellitus. Diabetes Res Clin Pract. 2010;88(1):81–86.
   PubMed Web of Science ®Google Scholar
• Akinci B, Celtik A, Yener S, et al. Is fasting glucose level during oral glucose tolerance test an indicator of the insulin need in gestational diabetes? Diabetes Res Clin Pract. 2008;82(2):219–225.
   PubMed Web of Science ®Google Scholar
• Wong VW, Jalaludin B. Gestational diabetes mellitus: who requires insulin therapy? Aust N Z J Obstet Gynaecol. 2011;51(5):432–436.
   PubMed Web of Science ®Google Scholar
• Mendez-Figueroa H, Daley J, Lopes VV, et al. Predicting the need for medical therapy in patients with mild gestational diabetes. Am J Perinatol. 2014;31(2):105–112.
   PubMed Web of Science ®Google Scholar
• Karatas A, Tunçay Işikkent N, Ozlü T, et al. Relationship of maternal serum resistin and visfatin levels with gestational diabetes mellitus. Gynecol Endocrinol. 2014;30(5):2012.
   Web of Science ®Google Scholar
• Lain KY, Daftary AR, Ness RB, et al. First trimester adipocytokine concentrations and risk of developing gestational diabetes later in pregnancy. Clin Endocrinol (Oxf). 2008;69(3):407–411.
   PubMed Web of Science ®Google Scholar
• Lappas M, Yee K, Permezel M, et al. Release and regulation of leptin, resistin and adiponectin from human placenta, fetal membranes, and maternal adipose tissue and skeletal muscle from normal and gestational diabetes mellitus-complicated pregnancies. J Endocrinol. 2005;186(3):457–465.
   PubMed Web of Science ®Google Scholar
• Megia A, Vendrell J, Gutierrez C, et al. Insulin sensitivity and resistin levels in gestational diabetes mellitus and after parturition. Eur J Endocrinol. 2008;158(2):173–178.
   PubMed Web of Science ®Google Scholar
• Sokup A, Szymański M, Góralczyk K. Impaired fasting glucose as a marker of heterogeneity of gestational diabetes mellitus. A study of 1025 women living in the region of Kuyavia and Pomerania in Poland. Endokrynol Pol. 2009;60(5):348–352.
   PubMed Web of Science ®Google Scholar
• Sokup A, Ruszkowska-Ciastek B, Góralczyk K, et al. Insulin resistance as estimated by the homeostatic method at diagnosis of gestational diabetes: estimation of disease severity and therapeutic needs in a population-based study. BMC Endocr Disord. 2013;13:21.
   PubMed Web of Science ®Google Scholar
• Barnes RA, Wong T, Ross GP, et al. A novel validated model for the prediction of insulin therapy initiation and adverse perinatal outcomes in women with gestational diabetes mellitus. Diabetologia. 2016;59(11):2331–2338.
   PubMed Web of Science ®Google Scholar